a-D2PV Crystal chunks

a-D2PV

a-D2PV (alpha-Dipyrrolidinovalerophenone)

PRODUCT DETAILS TABLE

 

 

Specification Details
Brand Biosynlab
Product Name a-D2PV (alpha-Dipyrrolidinovalerophenone)
IUPAC Name 1-(2-pyrrolidin-1-ylpentan-2-yl)-2-pyrrolidin-1-ylethanone
CAS Number Not assigned / Novel research compound
Molecular Formula C₁₅H₂₆N₂O
Molecular Weight 250.38 g/mol
Chemical Class Dipyrrolidinophenone / Stimulant
Purity ≥99.0% (HPLC Verified)
Appearance White to off-white crystalline powder
Melting Point 168-174°C (hydrochloride salt)
Solubility Soluble in DMSO, ethanol, methanol; moderately soluble in water
Storage -20°C, desiccated, away from light
Packaging Amber glass vial with PTFE seal
Quantities 250mg, 500mg, 1g, 5g, 10g, 25g, bulk
Analysis COA, NMR, MS, FTIR included
Shipping Express courier, tracked, discreet
Regions USA, UK, Germany, Netherlands, EU, Canada

a-D2PV (alpha-Dipyrrolidinovalerophenone) represents a novel dipyrrolidinophenone compound that has garnered significant attention in neuropharmacological research for its unique structural architecture featuring dual pyrrolidine moieties. As a structural evolution of the pyrovalerone scaffold, a-D2PV offers distinct pharmacological properties that make it invaluable for structure-activity relationship studies, particularly in investigations of monoamine transporter pharmacology and stimulant mechanism research. Biosynlab delivers analytical-grade a-D2PV with certified ≥99.0% purity, supporting cutting-edge research across USA, United Kingdom, European Union, and international scientific markets.

The innovative dipyrrolidinyl substitution pattern distinguishes a-D2PV from traditional mono-pyrrolidinophenone compounds, potentially altering binding kinetics at dopamine and norepinephrine transporters. This structural novelty positions a-D2PV as an important tool compound for investigating polypharmacology in stimulant compounds and understanding the relationship between molecular architecture and transporter selectivity. Researchers at institutions in London, Berlin, Amsterdam, New York, and Los Angeles utilize Biosynlab a-D2PV for investigations into novel psychoactive substances (NPS) pharmacology and forensic analytical method development.

Showing the single result